X-linked Agammaglobulinemia is rare primary immunodeficiency disorder. X-linked Agammaglobulinemia is caused by a mutation on the BTK gene, the gene that is responsible for making B-cells, the cells that later develop into antibodies. As a result of this mutation and the lack of antibodies, people with X-linked Agammaglobulinemia are unable to fend off infections. Because it is an X-linked disease, the majority of people who have X-linked Agammaglobulinemia are men and are diagnosed with the disease when they are babies. Although there is no cure for the disease, treatment options such as immunoglobin replacement therapy and heavy antibiotic use are available.
X-linked Agammaglobulinemia Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on X-linked Agammaglobulinemia below!
For more information on how to use Laverne, please read the How to Guide.
We have 2580 products for the study of X-linked Agammaglobulinemia that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.